Interestingly, enhanced apoptosis and DNA damage were observed, along with an increase in GAS5 level and decreased miR-18a-5p expression, in prostate cancer cells treated with α-Solanine, suggesting that targeting GAS5/miR-18a-5p can be utilized to treat prostate cancer in the presence of α-Solanine [51]. Here, GAS5 is linked to prostate carcinoma.